select a format

Single User License
USD 2000 INR 128360
Site License
USD 4000 INR 256720
Corporate User License
USD 6000 INR 385080

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Visceral Pain-Pipeline Review, H2 2016

Visceral Pain-Pipeline Review, H2 2016


  • Products Id :- GMDHC8432IDB
  • |
  • Pages: 58
  • |
  • August 2016
  • |
  • |
  Request for Sample Report

Executive Summary

Visceral Pain-Pipeline Review, H2 2016

Summary

Global Markets Direct's, 'Visceral Pain-Pipeline Review, H2 2016', provides an overview of the Visceral Pain pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Visceral Pain, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Visceral Pain and features dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the global therapeutic landscape of Visceral Pain

The report reviews pipeline therapeutics for Visceral Pain by companies and universities/research institutes based on information derived from company and industry-specific sources

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report reviews key players involved Visceral Pain therapeutics and enlists all their major and minor projects

The report assesses Visceral Pain therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report summarizes all the dormant and discontinued pipeline projects

The report reviews latest news related to pipeline therapeutics for Visceral Pain

Reasons to Buy

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Visceral Pain

Identify potential new clients or partners in the target demographic

Develop strategic initiatives by understanding the focus areas of leading companies

Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Visceral Pain pipeline depth and focus of Indication therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 5

Introduction 6

Global Markets Direct Report Coverage 6

Visceral Pain Overview 7

Therapeutics Development 8

Pipeline Products for Visceral Pain-Overview 8

Pipeline Products for Visceral Pain-Comparative Analysis 9

Visceral Pain-Therapeutics under Development by Companies 10

Visceral Pain-Therapeutics under Investigation by Universities/Institutes 11

Visceral Pain-Pipeline Products Glance 12

Clinical Stage Products 12

Early Stage Products 13

Visceral Pain-Products under Development by Companies 14

Visceral Pain-Products under Investigation by Universities/Institutes 15

Visceral Pain-Companies Involved in Therapeutics Development 16

Addex Therapeutics Ltd 16

Astellas Pharma Inc. 17

Chromocell Corporation 18

GIcare Pharma Inc 19

Grunenthal GmbH 20

Medestea Research & Production S.p.A. 21

Neurim Pharmaceuticals Ltd 22

Pfizer Inc. 23

Visceral Pain-Therapeutics Assessment 24

Assessment by Monotherapy Products 24

Assessment by Target 25

Assessment by Mechanism of Action 27

Assessment by Route of Administration 29

Assessment by Molecule Type 30

Drug Profiles 32

ADX-71441-Drug Profile 32

Product Description 32

Mechanism Of Action 32

R&D Progress 32

ADX-71743-Drug Profile 36

Product Description 36

Mechanism Of Action 36

R&D Progress 36

ASP-7663-Drug Profile 37

Product Description 37

Mechanism Of Action 37

R&D Progress 37

CC-8464-Drug Profile 38

Product Description 38

Mechanism Of Action 38

R&D Progress 38

GIC-1002-Drug Profile 40

Product Description 40

Mechanism Of Action 40

R&D Progress 40

MED-1101-Drug Profile 41

Product Description 41

Mechanism Of Action 41

R&D Progress 41

Monoclonal Antibody to Antagonize P2X2 and P2X3 for Visceral Pain-Drug Profile 42

Product Description 42

Mechanism Of Action 42

R&D Progress 42

NEO-5937-Drug Profile 43

Product Description 43

Mechanism Of Action 43

R&D Progress 43

NeuP-12-Drug Profile 44

Product Description 44

Mechanism Of Action 44

R&D Progress 44

piromelatine-Drug Profile 45

Product Description 45

Mechanism Of Action 45

R&D Progress 45

PR-38-Drug Profile 47

Product Description 47

Mechanism Of Action 47

R&D Progress 47

RO-656570-Drug Profile 48

Product Description 48

Mechanism Of Action 48

R&D Progress 48

SBFI-26-Drug Profile 49

Product Description 49

Mechanism Of Action 49

R&D Progress 49

Small Molecule to Block Nav1.9 Channel for Pain-Drug Profile 50

Product Description 50

Mechanism Of Action 50

R&D Progress 50

Synthetic Peptides to Activate OXTR for Oncology and Abdominal Pain-Drug Profile 51

Product Description 51

Mechanism Of Action 51

R&D Progress 51

URB-937-Drug Profile 52

Product Description 52

Mechanism Of Action 52

R&D Progress 52

Visceral Pain-Dormant Projects 53

Visceral Pain-Discontinued Products 56

Appendix 57

Methodology 57

Coverage 57

Secondary Research 57

Primary Research 57

Expert Panel Validation 57

Contact Us 57

Disclaimer 58

List of Figures

Number of Products under Development for Visceral Pain, H2 2016 8

Number of Products under Development for Visceral Pain-Comparative Analysis, H2 2016 9

Number of Products under Development by Companies, H2 2016 10

Comparative Analysis by Early Stage Products, H2 2016 13

Assessment by Monotherapy Products, H2 2016 24

Number of Products by Top 10 Targets, H2 2016 25

Number of Products by Stage and Top 10 Targets, H2 2016 25

Number of Products by Top 10 Mechanism of Actions, H2 2016 27

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2016 27

Number of Products by Stage and Routes of Administration, H2 2016 29

Number of Products by Molecule Types, H2 2016 30

Number of Products by Stage and Molecule Types, H2 2016 30

List of Tables

Number of Products under Development for Visceral Pain, H2 2016 8

Number of Products under Development for Visceral Pain-Comparative Analysis, H2 2016 9

Number of Products under Development by Companies, H2 2016 10

Number of Products under Investigation by Universities/Institutes, H2 2016 11

Comparative Analysis by Clinical Stage Development, H2 2016 12

Comparative Analysis by Early Stage Development, H2 2016 13

Products under Development by Companies, H2 2016 14

Products under Investigation by Universities/Institutes, H2 2016 15

Visceral Pain-Pipeline by Addex Therapeutics Ltd, H2 2016 16

Visceral Pain-Pipeline by Astellas Pharma Inc., H2 2016 17

Visceral Pain-Pipeline by Chromocell Corporation, H2 2016 18

Visceral Pain-Pipeline by GIcare Pharma Inc, H2 2016 19

Visceral Pain-Pipeline by Grunenthal GmbH, H2 2016 20

Visceral Pain-Pipeline by Medestea Research & Production S.p.A., H2 2016 21

Visceral Pain-Pipeline by Neurim Pharmaceuticals Ltd, H2 2016 22

Visceral Pain-Pipeline by Pfizer Inc., H2 2016 23

Assessment by Monotherapy Products, H2 2016 24

Number of Products by Stage and Target, H2 2016 26

Number of Products by Stage and Mechanism of Action, H2 2016 28

Number of Products by Stage and Route of Administration, H2 2016 29

Number of Products by Stage and Molecule Type, H2 2016 31

Visceral Pain-Dormant Projects, H2 2016 53

Visceral Pain-Dormant Projects (Contd..1), H2 2016 54

Visceral Pain-Dormant Projects (Contd..2), H2 2016 55

Visceral Pain-Discontinued Products, H2 2016 56

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Addex Therapeutics Ltd

Astellas Pharma Inc.

Chromocell Corporation

GIcare Pharma Inc

Grunenthal GmbH

Medestea Research & Production S.p.A.

Neurim Pharmaceuticals Ltd

Pfizer Inc.

Visceral Pain Therapeutic Products under Development, Key Players in Visceral Pain Therapeutics, Visceral Pain Pipeline Overview, Visceral Pain Pipeline, Visceral Pain Pipeline Assessment


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com